Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03277105
Brief Title: A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

First Submitted : September 7, 2017
First Submitted that Met QC Criteria : September 7, 2017
First Posted : September 8, 2017

Results First Submitted : June 19, 2020
Results First Submitted that Met QC Criteria : July 24, 2020
Results First Posted : July 27, 2020

Last Update Submitted that Met QC Criteria : April 22, 2021
Last Update Posted : April 26, 2021